Between-group comparisons were significant in CRP, TNF-α, and IL-6 at 3 months after adjustment.<h4>Conclusions</h4>These preliminary findings suggest that adjunctive berberine therapy may improve anthropometric, hormonal, metabolic, and inflammatory profiles in women with PCOS. The gene discussed is IL6; the disease is polycystic ovary syndrome.